Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.

Donación Donation Infección Infection Solid organ transplantation Transmisión Transmission Trasplante de órgano sólido

Journal

Enfermedades infecciosas y microbiologia clinica (English ed.)
ISSN: 2529-993X
Titre abrégé: Enferm Infecc Microbiol Clin (Engl Ed)
Pays: Spain
ID NLM: 101777541

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 21 10 2019
accepted: 22 10 2019
pubmed: 25 12 2019
medline: 24 8 2021
entrez: 25 12 2019
Statut: ppublish

Résumé

The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence.

Identifiants

pubmed: 31870646
pii: S0213-005X(19)30316-7
doi: 10.1016/j.eimc.2019.10.016
pii:
doi:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

379-389

Informations de copyright

Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Auteurs

Oscar Len (O)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain. Electronic address: oscar.len@vhir.org.

Ibai Los-Arcos (I)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

José María Aguado (JM)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Marino Blanes (M)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Marta Bodro (M)

Hospital Clínic-IDIBAPS, Barcelona, Spain.

Jordi Carratalà (J)

Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain.

Elisa Cordero (E)

Hospital Virgen del Rocío, Sevilla, Spain.

María Carmen Fariñas (MC)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Mario Fernández-Ruiz (M)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Jesús Fortún (J)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Joan Gavaldà (J)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Francisco López-Medrano (F)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Rogelio López-Vélez (R)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Carlos Lumbreras (C)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Beatriz Mahillo (B)

Organización Nacional de Trasplantes, Madrid, Spain.

María Ángeles Marcos (MÁ)

Hospital Clínic, Barcelona, Spain.

Pilar Martin-Dávila (P)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

José Miguel Montejo (JM)

Hospital Universitario de Cruces, Vizcaya, Spain.

Asunción Moreno (A)

Hospital Clínic-IDIBAPS, Barcelona, Spain.

Patricia Muñoz (P)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Francesca Norman (F)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

José Luis Pérez-Sáenz (JL)

Hospital Universitario Son Espases, Palma de Mallorca, Spain.

Tomás Pumarola (T)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Núria Sabé (N)

Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain.

Rafael San-Juan (R)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Elisa Vidal (E)

Hospital Universitario Reina Sofía, Córdoba, Spain.

Beatriz Domínguez-Gil (B)

Organización Nacional de Trasplantes, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH